They signal traceability and standards, not efficacy or medical approval
The 2013 Nobel Prize clarified how cells ship cargo in vesicles—the playbook behind how we handle exosomes. Helpful context, but it’s not a shortcut to regulatory approval.
-
DMF / INCI / quality-system certificates ≠ an official endorsement of efficacy or medical use.
-
They prove documentation is on file, naming is standardized, and manufacturing/QA is controlled—not that any authority approved cosmetic claims or medical indications.
What each one means (and doesn’t)
|
Name |
What it is |
What it isn’t |
How we use it (ExoPureBeauty) |
|---|---|---|---|
|
DMF (Drug Master File) |
A confidential dossier submitted by an upstream ingredient supplier to a regulator; can be referenced (via LoA) in drug applications for technical review. |
Not an approval of a drug or a cosmetic; not proof of efficacy/indications. |
A traceability artifact in our supply due-diligence and recordkeeping. We never present a DMF as a consumer efficacy promise. |
|
INCI name |
The international naming system for cosmetic ingredients; used on labels so formulas are readable across markets. |
Not a “certified effect,” and not a blanket safety/efficacy guarantee. |
All listed products follow the outer-box INCI. On request, we share an Ingredients Tech Brief / QC Snapshot (no trade secrets). |
|
Quality systems (e.g., ISO 22716 GMP, ISO 9001) |
Evidence a company runs a documented quality-management system (people/site/documents/traceability/deviation handling). |
Not a market authorization, not a claims endorsement, and not a substitute for local filings/label compliance. |
We pair system discipline with batch release testing and Fresh-Batch 48h + per-vial traceability to keep the process verifiable. |
Also: Markets may require product notifications/registrations/label compliance. These are entry prerequisites and documentation steps—still not approvals of efficacy or medical use.
Why we care (without calling it a “badge of efficacy”)
-
Traceable: Raw materials and manufacturing trails are auditable (COA snapshots, micro limits, key physico-chemical specs, change control).
-
Comparable: INCI naming lets you read across brands and understand what’s inside.
-
Auditable: Quality systems create a path to investigate deviations, complaints, and adverse events.
These are proofs that the process is solid—not guarantees about the result on your skin.
Your verifiable chain with us
-
Fresh-Batch 48h: Within 48 hours of order, we assign the latest released batch, print per-vial labels, and ship temperature-controlled.
-
Use transparency: Freeze-dry + dedicated solvent, one vial = one use; if you must split, refrigerate at 2–8 °C and finish within 48 h. Post-needling, apply within 0–60 min, then keep the 72 h simplify-and-shield protocol (see Q11/Q12/Q13).
-
Clear boundary: We only speak to cosmetic outcomes—cleanse, hydrate, soothe, support the barrier (see Q21/Q32). No medical uses.
Quick FAQ
Does a DMF / ISO certificate mean “more effective”?
No. It shows the paperwork and process are more structured. Your experience still depends on skin condition, timing, and how you use it.
Does having an INCI mean “absolutely safe”?
No. INCI is a naming system. Safety depends on formulation, concentration, use scenario, and your tolerance. Patch test 24–48 h if you’re sensitive.
Can you share certificates?
We can share necessary summaries under compliance (e.g., COA excerpts, selected system evidence) without trade secrets.
Compliance notice
Our products are cosmetics for the surface of the skin—cleanse, hydrate, soothe, and support the barrier. They are not intended to diagnose, treat, or prevent disease. Documentation such as DMF/INCI/ISO demonstrates traceability and good practice, not efficacy or medical approval.
One-line wrap-up
Treat DMF / INCI / quality systems as the road and streetlights—making origin, process, and labeling transparent. They don’t replace results. Within cosmetic boundaries, we keep exosome care clean, traceable, and executable.
Read more
It’s an informational map, not a product promise The 2013 Nobel Prize mapped how cells move cargo in tiny vesicles—the playbook that helps us understand and handle exosomes. It opens intriguing p...
The most accurate way is to count vials × cadence The 2013 Nobel Prize showed how cells ship cargo in vesicles—this underpins how we make and handle exosomes today. Pro (1+1): ≈ 1 in-clinic ...